News & Events

Latest press releases, events, presentations & media assets

Latest Press Releases

Sep 12, 2017 • 7:00am EDT

Synthetic Biologics Announces Closing of $12 Million Convertible Preferred Stock Financing

ROCKVILLE, Md., Sept. 12, 2017 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE American: SYN), a late-stage clinical company developing therapeutics that preserve the microbiome to protect and restore the health of patients, announced today the closing of a privately placed stock purchase transaction for the sale of redeemable convertible preferred stock to an affiliate of MSD Partners, L.P. for aggregate gross proceeds of $12 million. ...

Read Press Release

Upcoming/Latest Events

Fifth World Congress on Targeting Microbiota

View All

Latest Publication

Gottlieb K et al. Review article: inhibition of methanogenic archaea by statins as a targeted management strategy for constipation and related disorders. Aliment Pharmacol Ther. 2015 Nov 11.

View Publication